GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (STU:25I) » Definitions » Dividend-Payout-to-FFO

ImmuPharma (STU:25I) Dividend-Payout-to-FFO


View and export this data going back to 2012. Start your Free Trial

What is ImmuPharma Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


ImmuPharma (STU:25I) Business Description

Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus and a life-threatening autoimmune disease.